LCxLC

Can Chromatography Help to Combat Viral Infections?

May 16 2018 Read 318 Times

Viral infections are incredibly common. Flu, the common cold and cold sores are all the result of viruses. Hence, the plea to stop asking for antibiotics to tackle the head cold you picked up last week. Viruses do not get killed by antibiotics— only bacteria do.

Viruses can also cause some nasty infections too. Smallpox and HIV/AIDS are both caused by viruses. Millions of people die each year because of viral infections. Viral infections can be controlled by vaccination programs. Polio, measles, hepatitis B and human papillomavirus can all be prevented by vaccinations. But treatment of viral infections is more difficult than bacterial infection treatment. A recent project commissioned by the European Commission has been using chromatography to help investigate viruses to understand the key processes in immunity and infection.

Bacteria and virus

Bacterial and viral infections can have many areas in common — coughing, sneezing and vomiting, spread through similar means like contact with people or surfaces, and the ability to cause mild or severe diseases. But the actual organisms are structurally very different.

Both viruses and bacteria are microscopic. Bacteria are single-celled organisms — living cells — that are possible the oldest single-celled organism to have evolved on Earth. They don’t have a defined nucleus but have an outer rigid wall and thin membrane surrounding the cell contents. Many bacteria can be harmless — in fact, some bacteria are needed for a healthy life as they help us to digest food and fight cancer cells.

In comparison to bacteria, viruses are tiny with the largest virus smaller than the smallest bacteria. Viruses have a protein coat and contain genetic material. But whereas bacteria can survive on their own, viruses need a host to live in. They reproduce by attaching themselves to cells and programming the cells to make more viruses. Viruses are more likely to cause disease.

EC targets virus infections

The recent work sponsored by the European Commission was carried out with the aim of developing technology to help analyse glycans to better understand viruses and viral infections. Glycans are chains of monosaccharides found on cell surfaces that viruses like to bind to. Knowing more about the role of glycan-virus interactions will allow researchers to gain a better understanding of how a virus can take control of a cell.

One of the techniques used in the process was chromatography to allow the fast separation of complex biological samples. Two-dimensional chromatography is a powerful tool for separating complex mixtures as discussed in the article, New Investigator Tools for Finding Unique and Common Components in Multiple Samples with Comprehensive Two-Dimensional Chromatography.

In a press release, the team report that good progress was made in developing a technique to analyse the glycans, with the team overcoming great technical difficulties. The future could be a little brighter when it comes to developing vaccines and drugs to target viruses because of the work.

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Chromatography Today - March 2018 Volume 11 Issue 1

March 2018

In This Issue... Articles - Industrial Applications of Offline and Online Comprehensive Gas Chromatography - Improving Workflow in Group-Type GC×GC Analysis of Petrochemicals - Identifi ca...

View all digital editions

Events

ASMS Conference

Jun 03 2018 San Diego, CA, USA

ACHEMA 2018

Jun 11 2018 Frankfurt, Germany

ISMM 2018

Jun 19 2018 Busan, Korea

PREP 2018

Jul 08 2018 Baltimore, MD, USA

HPLC 2018

Jul 29 2018 Washington DC, USA

View all events